Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vertex announces retirement of Peter Mueller

This article was originally published in Scrip

Executive Summary

Vertex Pharmaceuticals has announced that Dr Peter Mueller, its executive vice-president of global research and development and chief scientific officer, will retire after more than 10 years with the company. Dr Mueller's retirement will be effective 31 October 2014, following a planned transition period, Vertex said. He joined the Boston, Massachusetts-based company in 2003 as chief scientific officer and senior vice-president, drug discovery and innovation. Vertex expects to appoint a new head of global research to oversee the company's drug discovery efforts following Dr Mueller's retirement later this year.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts